Godavari Biorefineries Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
GODAVARIB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.2 pts less than Nifty Microcap 250 and 3.5 pts less than its Fast Moving Consumer Goods peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Godavari Biorefineries submitted its unaudited Q1 FY26 results (quarter ended June 30, 2025). Consolidated revenue from operations rose modestly to Rs. 533.24 crore from Rs. 522.53 crore in Q1 FY25 (~2% growth). Net loss narrowed sharply to Rs. 16.02 crore versus Rs. 26.11 crore in the same quarter last year, with EPS improving to Rs. (3.13) from Rs. (6.22). Total expenses declined to Rs. 556.28 crore from Rs. 566.91 crore. Segments-wise, Sugar and Cogeneration posted operating losses, while Bio-based Chemicals and Distillery remained profitable. The Board also appointed two new Non-Executive Independent Directors (Mr. Nandan Mehta and Mr. Sean Reagan), re-appointed Mr. Hemant Luthra as Independent Director, and named Mr. Shreyans Gang as Deputy CFO. The 70th AGM is scheduled for September 30, 2025. IPO proceeds of Rs. 325 crore have been largely deployed (Rs. 322.91 crore utilised by June 30, 2025), primarily for debt repayment.
Losses continue but are narrowing meaningfully, offering some relief to shareholders. However, profitability remains elusive and the seasonal nature of the sugar business makes Q1 not representative of full-year performance. Stock price reaction may be muted unless the narrowing loss trend continues into stronger quarters (Q2-Q3 are typically better for sugar players).